
    
      The clinical trial contains a patient collective of 50 (6-60 years of age) that shall be
      eventually compared to a control group equal in age and gender. Both the patients and the
      healthy subjects are recruited from the outpatient clinic of Pediatric Allergy and
      Pulmonology.

      Methods and Work Programme:

      This study consists of two study visits (V1 and V2)

      V1:

        -  Measurement of nitric oxide in expired air (eNO)

        -  Measurement of carbon monoxide in the exhaled air (eCO)

        -  Lung function testing with spirography and bodyplethysmographie

        -  Blood test: blood count, CRP, RAST, serum inflammatory mediators, genetic markers of the
           non-specific pulmonary defense system

        -  Induced sputum for inflammatory mediators and microbiological investigations

      V2:

      *Unspecific bronchial provocation test with methacholine (PD20 FEV1 metacholine)
    
  